Publications

  1. Matchett WE, Anguiano-Zarate SS, Nehete PN, Shelton K, Nehete BP, Yang G, Dorta-Estremera S, Barnette P, Xiao P, Byrareddy SN, Villinger F, Hessell AJ, Haigwood NL, Sastry KJ, Barry MA. Divergent HIV-1-Directed Immune Responses Generated by Systemic and Mucosal Immunization with Replicating Single-Cycle Adenoviruses in Rhesus Macaques. J Virol. 2019 May 15; 93 (10) Epub 2019 May 01
    View PubMed
  2. Parks CA, Henning KR, Pavelko KD, Hansen MJ, Van Keulen VP, Reed BK, Stone JD, Schrum AG, Gil D, Kranz DM, Bordner AJ, Barry MA, Pease LR. Breaking tolerance with engineered class I antigen-presenting molecules. Proc Natl Acad Sci U S A. 2019 Feb 19; 116 (8):3136-3145 Epub 2019 Feb 06
    View PubMed
  3. Anguiano-Zarate SS, Matchett WE, Nehete PN, Sastry JK, Marzi A, Barry MA. A Replicating Single-Cycle Adenovirus Vaccine Against Ebola Virus. J Infect Dis. 2018 Nov 5; 218 (12):1883-1889
    View PubMed
  4. WareJoncas Z, Campbell JM, Martinez-Galvez G, Gendron WAC, Barry MA, Harris PC, Sussman CR, Ekker SC. Precision gene editing technology and applications in nephrology. Nat Rev Nephrol. 2018 Nov; 14 (11):663-677
    View PubMed
  5. Matchett WE, Anguiano-Zarate SS, Barry MA. Comparison of systemic and mucosal immunization with replicating Single cycle Adenoviruses. Glob Vaccines Immunol. 2018 Sep; 3 (1) Epub 2018 May 15
    View PubMed
  6. Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW Jr, Kemper AR, Kubik M, Landefeld CS, Mangione CM, Silverstein M, Simon MA, Tseng CW, Wong JB, US Preventive Services Task Force. Screening for Peripheral Artery Disease and Cardiovascular Disease Risk Assessment With the Ankle-Brachial Index: US Preventive Services Task Force Recommendation Statement. JAMA. 2018 Jul 10; 320 (2):177-183
    View PubMed
  7. Matteson NL, Barry MA, Reddy VS. Structure-based assessment of protein-protein interactions and accessibility of protein IX in adenoviruses with implications for antigen display. Virology. 2018 Mar; 516:102-107 Epub 2018 Jan 11
    View PubMed
  8. Barry M. Single-cycle adenovirus vectors in the current vaccine landscape. Expert Rev Vaccines. 2018 Feb; 17 (2):163-173 Epub 2018 Jan 18
    View PubMed
  9. Nguyen TV, Anguiano-Zarate SS, Matchett WE, Barry ME, Barry MA. Retargeted and detargeted adenovirus for gene delivery to the muscle. Virology. 2018 Jan 15; 514:118-123 Epub 2017 Nov 22
    View PubMed
  10. Nguyen TV, Crosby CM, Heller GJ, Mendel ZI, Barry ME, Barry MA. Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer. Oncolytic Virother. 2018; 7:43-51 Epub 2018 May 03
    View PubMed
  11. Nguyen TV, Barry ME, Turner MA, Crosby CM, Trujillo MA, Morris JC, Barry MA. Comparison of Liver Detargeting Strategies for Systemic Therapy with Oncolytic Adenovirus Serotype 5. Biomedicines. 2017 Aug 10; 5 (3)
    View PubMed
  12. Rivera-Barahona A, Fulgencio-Covian A, Perez-Cerda C, Ramos R, Barry MA, Ugarte M, Perez B, Richard E, Desviat LR. Dysregulated miRNAs and their pathogenic implications for the neurometabolic disease propionic acidemia. Sci Rep. 2017 Jul 18; 7 (1):5727 Epub 2017 July 18
    View PubMed
  13. Yu X, Veesler D, Campbell MG, Barry ME, Asturias FJ, Barry MA, Reddy VS. Cryo-EM structure of human adenovirus D26 reveals the conservation of structural organization among human adenoviruses. Sci Adv. 2017 May; 3 (5):e1602670 Epub 2017 May 10
    View PubMed
  14. Crosby CM, Barry MA. Transgene Expression and Host Cell Responses to Replication-Defective, Single-Cycle, and Replication-Competent Adenovirus Vectors. Genes (Basel). 2017 Feb 18; 8 (2)
    View PubMed
  15. Crosby CM, Matchett WE, Anguiano-Zarate SS, Parks CA, Weaver EA, Pease LR, Webby RJ, Barry MA. Replicating Single-Cycle Adenovirus Vectors Generate Amplified Influenza Vaccine Responses. J Virol. 2017 Jan 15; 91 (2) Epub 2017 Jan 03
    View PubMed
  16. Dorta-Estremera S, Nehete PN, Yang G, He H, Nehete BP, Shelton KA, Barry MA, Sastry KJ. Minimally invasive monitoring of CD4 T cells at multiple mucosal tissues after intranasal vaccination in rhesus macaques. PLoS One. 2017; 12 (12):e0188807 Epub 2017 Dec 08
    View PubMed
  17. Couturier J, Agarwal N, Nehete PN, Baze WB, Barry MA, Jagannadha Sastry K, Balasubramanyam A, Lewis DE. Infectious SIV resides in adipose tissue and induces metabolic defects in chronically infected rhesus macaques. Retrovirology. 2016 Apr 27; 13:30
    View PubMed
  18. Singh S, Schluns KS, Yang G, Anthony SM, Barry MA, Sastry KJ. Intranasal Vaccination Affords Localization and Persistence of Antigen-Specific CD8(+) T Lymphocytes in the Female Reproductive Tract. Vaccines (Basel). 2016 Mar 17; 4 (1)
    View PubMed
  19. Kang L, Grande JP, Hillestad ML, Croatt AJ, Barry MA, Katusic ZS, Nath KA. A new model of an arteriovenous fistula in chronic kidney disease in the mouse: beneficial effects of upregulated heme oxygenase-1. Am J Physiol Renal Physiol. 2016 Mar 15; 310 (6):F466-76 Epub 2015 Dec 16
    View PubMed
  20. Nguyen TV, Heller GJ, Barry ME, Crosby CM, Turner MA, Barry MA. Evaluation of polymer shielding for adenovirus serotype 6 (Ad6) for systemic virotherapy against human prostate cancers. Mol Ther Oncolytics. 2016; 3 Epub 2016 Feb 03
    View PubMed
  21. Ruan MZ, Cerullo V, Cela R, Clarke C, Lundgren-Akerlund E, Barry MA, Lee BH. Treatment of osteoarthritis using a helper-dependent adenoviral vector retargeted to chondrocytes. Mol Ther Methods Clin Dev. 2016; 3:16008 Epub 2016 Mar 09
    View PubMed
  22. Turner MA, Middha S, Hofherr SE, Barry MA. Comparison of the Life Cycles of Genetically Distant Species C and Species D Human Adenoviruses Ad6 and Ad26 in Human Cells. J Virol. 2015 Dec; 89 (24):12401-17 Epub 2015 Sept 30
    View PubMed
  23. Crosby CM, Weaver EA, Khare R, Barry MA. A Novel Codon-optimized SIV Gag-pol Immunogen for Gene-based Vaccination. Virol Rep. 2015 Dec 1; 5:47-55 Epub 2015 Mar 10
    View PubMed
  24. Weaver EA, Camacho ZT, Hillestad ML, Crosby CM, Turner MA, Guenzel AJ, Fadel HJ, Mercier GT, Barry MA. Mucosal vaccination by adenoviruses displaying reovirus sigma 1. Virology. 2015 Aug; 482:60-6 Epub 2015 Mar 30
    View PubMed
  25. Kang L, Hillestad ML, Grande JP, Croatt AJ, Barry MA, Farrugia G, Katusic ZS, Nath KA. Induction and functional significance of the heme oxygenase system in pathological shear stress in vivo. Am J Physiol Heart Circ Physiol. 2015 Jun 1; 308 (11):H1402-13 Epub 2015 Mar 27
    View PubMed
  26. Guenzel AJ, Collard R, Kraus JP, Matern D, Barry MA. Long-term sex-biased correction of circulating propionic acidemia disease markers by adeno-associated virus vectors. Hum Gene Ther. 2015 Mar; 26 (3):153-60
    View PubMed
  27. Tonne JM, Sakuma T, Munoz-Gomez M, El Khatib M, Barry MA, Kudva YC, Ikeda Y. Beta cell regeneration after single-round immunological destruction in a mouse model. Diabetologia. 2015 Feb; 58 (2):313-23 Epub 2014 Oct 23
    View PubMed
  28. Crosby CM, Nehete P, Sastry KJ, Barry MA. Amplified and persistent immune responses generated by single-cycle replicating adenovirus vaccines. J Virol. 2015 Jan; 89 (1):669-75 Epub 2014 Oct 29
    View PubMed
  29. Hofherr SE, Barry MA. Near infrared fluorescence imaging to determine injection success in small animals Current Molecular Imaging. 2015; 4 (1):53-6
  30. Singh S, Yang G, Byrareddy SN, Barry MA, Sastry KJ. Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein. Vaccine. 2014 Dec 5; 32 (51):6934-6940 Epub 2014 Nov 02
    View PubMed
  31. Singh S, Nehete PN, Yang G, He H, Nehete B, Hanley PW, Barry MA, Sastry KJ. Enhancement of Mucosal Immunogenicity of Viral Vectored Vaccines by the NKT Cell Agonist Alpha-Galactosylceramide as Adjuvant. Vaccines (Basel). 2014 Oct 10; 2 (4):686-706
    View PubMed
  32. Guenzel AJ, Hillestad ML, Matern D, Barry MA. Effects of adeno-associated virus serotype and tissue-specific expression on circulating biomarkers of propionic acidemia. Hum Gene Ther. 2014 Sep; 25 (9):837-43 Epub 2014 Aug 21
    View PubMed
  33. Crosby CM, Barry MA. IIIa deleted adenovirus as a single-cycle genome replicating vector. Virology. 2014 Aug; 462-463:158-65 Epub 2014 July 02
    View PubMed
  34. Camacho ZT, Turner MA, Barry MA, Weaver EA. CD46-Mediated transduction of a species d adenovirus vaccine improves mucosal vaccine efficacy. Hum Gene Ther. 2014; 25(4):364-74.
    View PubMed
  35. Tonne JM, Sakuma T, Deeds MC, Munoz-Gomez M, Barry MA, Kudva YC, Ikeda Y. Global gene expression profiling of pancreatic islets in mice during streptozotocin-induced beta-cell damage and pancreatic Glp-1 gene therapy. Dis Model Mech. 2013 Sep; 6 (5):1236-45 Epub 2013 July 04
    View PubMed
  36. Guenzel AJ, Hofherr SE, Hillestad M, Barry M, Weaver E, Venezia S, Kraus JP, Matern D, Barry MA. Generation of a hypomorphic model of propionic acidemia amenable to gene therapy testing. Mol Ther. 2013 Jul; 21 (7):1316-23 Epub 2013 May 07
    View PubMed
  37. Khare R, Hillestad ML, Xu Z, Byrnes AP, Barry MA. Circulating antibodies and macrophages as modulators of adenovirus pharmacology. J Virol. 2013 Apr; 87 (7):3678-86 Epub 2013 Jan 16
    View PubMed
  38. Weaver EA, Barry MA. Low seroprevalent species D adenovirus vectors as influenza vaccines. PLoS One. 2013; 8 (8):e73313 Epub 2013 Aug 22
    View PubMed
  39. Weaver EA, Nehete PN, Nehete BP, Yang G, Buchl SJ, Hanley PW, Palmer D, Montefiori DC, Ferrari G, Ng P, Sastry KJ, Barry MA. Comparison of systemic and mucosal immunization with helper-dependent adenoviruses for vaccination against mucosal challenge with SHIV. PLoS One. 2013; 8 (7):e67574 Epub 2013 July 03
    View PubMed
  40. Hillestad ML, Guenzel AJ, Nath KA, Barry MA. A vector-host system to fingerprint virus tropism. Hum Gene Ther. 2012 Oct; 23 (10):1116-26
    View PubMed
  41. Cummins NW, Weaver EA, May SM, Croatt AJ, Foreman O, Kennedy RB, Poland GA, Barry MA, Nath KA, Badley AD. Heme oxygenase-1 regulates the immune response to influenza virus infection and vaccination in aged mice. FASEB J. 2012 Jul; 26 (7):2911-8 Epub 2012 Apr 06
    View PubMed
  42. Barry MA, Weaver EA, Chen CY. Mining the adenovirus "virome" for systemic oncolytics. Curr Pharm Biotechnol. 2012 Jul; 13(9):1804-8.
    View PubMed
  43. Sakuma T, Barry MA, Ikeda Y. Lentiviral vectors: basic to translational. Biochem J. 2012 May 1; 443(3):603-18.
    View PubMed
  44. Weaver EA, Mercier GT, Gottschalk S, Barry MA. T-cell-biased immune responses generated by a mucosally targeted adenovirus-sigma1 vaccine. Mucosal Immunol. 2012 May; 5 (3):311-9 Epub 2012 Feb 29
    View PubMed
  45. Khare R, Reddy VS, Nemerow GR, Barry MA. Identification of adenovirus serotype 5 hexon regions that interact with scavenger receptors. J Virol. 2012 Feb; 86 (4):2293-301 Epub 2011 Dec 07
    View PubMed
  46. Barry MA, May S, Weaver EA. Imaging luciferase-expressing viruses. Methods Mol Biol. 2012; 797:79-87
    View PubMed
  47. Chen CY, Senac JS, Weaver EA, May SM, Jelinek DF, Greipp P, Witzig T, Barry MA. Species D adenoviruses as oncolytics against B-cell cancers. Clin Cancer Res. 2011 Nov 1; 17 (21):6712-22 Epub 2011 Sept 02
    View PubMed
  48. Chen CY, Weaver EA, Khare R, May SM, Barry MA. Mining the adenovirus virome for oncolytics against multiple solid tumor types. Cancer Gene Ther. 2011 Oct; 18 (10):744-50 Epub 2011 Sept 02
    View PubMed
  49. Weaver EA, Chen CY, May SM, Barry ME, Barry MA. Comparison of adenoviruses as oncolytics and cancer vaccines in an immunocompetent B cell lymphoma model. Hum Gene Ther. 2011 Sep; 22 (9):1095-100 Epub 2011 Sept 06
    View PubMed
  50. Khare R, Chen CY, Weaver EA, Barry MA. Advances and future challenges in adenoviral vector pharmacology and targeting. Curr Gene Ther. 2011 Aug; 11 (4):241-58
    View PubMed
  51. Khare R, May SM, Vetrini F, Weaver EA, Palmer D, Rosewell A, Grove N, Ng P, Barry MA. Generation of a Kupffer cell-evading adenovirus for systemic and liver-directed gene transfer. Mol Ther. 2011 Jul; 19 (7):1254-62 Epub 2011 Apr 19
    View PubMed
  52. Chandler RJ, Chandrasekaran S, Carrillo-Carrasco N, Senac JS, Hofherr SE, Barry MA, Venditti CP. Adeno-associated virus serotype 8 gene transfer rescues a neonatal lethal murine model of propionic acidemia. Hum Gene Ther. 2011 Apr; 22: (4)477-81.
    View PubMed
  53. Weaver EA, Hillestad ML, Khare R, Palmer D, Ng P, Barry MA. Characterization of species C human adenovirus serotype 6 (Ad6). Virology. 2011 Mar 30; 412 (1):19-27 Epub 2011 Jan 20
    View PubMed
  54. Weaver EA, Rubrum AM, Webby RJ, Barry MA. Protection against divergent influenza H1N1 virus by a centralized influenza hemagglutinin. PLoS One. 2011 Mar 28; 6 (3):e18314
    View PubMed
  55. Hofherr SE, Adams KE, Chen CY, May S, Weaver EA, Barry MA. Real-time dynamic imaging of virus distribution in vivo. PLoS One. 2011 Feb 15; 6 (2):e17076
    View PubMed
  56. Sakuma T, Tonne JM, Squillace KA, Ohmine S, Thatava T, Peng KW, Barry MA, Ikeda Y. Early events in retrovirus XMRV infection of the wild-derived mouse Mus pahari. J Virol. 2011 Feb; 85 (3):1205-13 Epub 2010 Nov 17
    View PubMed
  57. Barry MA. Recombinant vector vaccines for the prevention and treatment of HIV infection. Drugs Future. 2011; 36(11):833-45.
  58. Chen CY, May SM, Barry MA. Targeting adenoviruses with factor x-single-chain antibody fusion proteins. Hum Gene Ther. 2010 Jun; 21: (6)739-49.
    View PubMed
  59. Senac JS, Doronin K, Russell SJ, Jelinek DF, Greipp PR, Barry MA. Infection and killing of multiple myeloma by adenoviruses. Hum Gene Ther. 2010 Feb; 21: (2)179-90.
    View PubMed
  60. Barry MA, Weaver EA, Hofherr SE. Rescue, amplification, purification, and PEGylation of replication defective first-generation adenoviral vectors. Methods Mol Biol. 2010; 651:227-39
    View PubMed
  61. Shashkova EV, May SM, Doronin K, Barry MA. Expanded anticancer therapeutic window of hexon-modified oncolytic adenovirus. Mol Ther. 2009 Dec; 17 (12):2121-30 Epub 2009 Sept 15
    View PubMed
  62. Weaver EA, Nehete PN, Nehete BP, Buchl SJ, Palmer D, Montefiori DC, Ng P, Sastry KJ, Barry MA. Protection against Mucosal SHIV Challenge by Peptide and Helper-Dependent Adenovirus Vaccines. Viruses. 2009 Dec 1; 1 (3):920
    View PubMed
  63. Shashkova EV, May SM, Barry MA. Characterization of human adenovirus serotypes 5, 6, 11, and 35 as anticancer agents. Virology. 2009 Nov 25; 394 (2):311-20 Epub 2009 Sept 18
    View PubMed
  64. Doronin K, Shashkova EV, May SM, Hofherr SE, Barry MA. Chemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirus. Hum Gene Ther. 2009 Sep; 20 (9):975-88
    View PubMed
  65. Barry MA, Hofherr SE, Chen CY, Senac JS, Hillestad ML, Shashkova EV. Systemic delivery of therapeutic viruses. Curr Opin Mol Ther. 2009 Aug; 11(4):411-20.
    View PubMed
  66. Tian J, Xu Z, Smith JS, Hofherr SE, Barry MA, Byrnes AP. Adenovirus activates complement by distinctly different mechanisms in vitro and in vivo: indirect complement activation by virions in vivo. J Virol. 2009 Jun; 83: (11)5648-58.
    View PubMed
  67. Poland GA, Barry MA. Common cold, uncommon variation. N Engl J Med. 2009 May 21; 360(21):2245-6.
    View PubMed
  68. Hofherr SE, Senac JS, Chen CY, Palmer DJ, Ng P, Barry MA. Short-term rescue of neonatal lethality in a mouse model of propionic acidemia by gene therapy. Hum Gene Ther. 2009 Feb; 20 (2):169-80
    View PubMed
  69. Weaver EA, Nehete PN, Buchl SS, Senac JS, Palmer D, Ng P, Sastry KJ, Barry MA. Comparison of replication-competent, first generation, and helper-dependent adenoviral vaccines. PLoS One. 2009; 4 (3):e5059 Epub 2009 Mar 31
    View PubMed
  70. Weaver EA, Barry MA. Effects of shielding adenoviral vectors with polyethylene glycol on vector-specific and vaccine-mediated immune responses. Hum Gene Ther. 2008 Dec; 19 (12):1369-82
    View PubMed
  71. Shashkova EV, Doronin K, Senac JS, Barry MA. Macrophage depletion combined with anticoagulant therapy increases therapeutic window of systemic treatment with oncolytic adenovirus. Cancer Res. 2008 Jul 15; 68(14):5896-904.
    View PubMed
  72. Hofherr SE, Shashkova EV, Weaver EA, Khare R, Barry MA. Modification of adenoviral vectors with polyethylene glycol modulates in vivo tissue tropism and gene expression. Mol Ther. 2008 Jul; 16: (7)1276-82.
    View PubMed
  73. Kalyuzhniy O, Di Paolo NC, Silvestry M, Hofherr SE, Barry MA, Stewart PL, Shayakhmetov DM. Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo. Proc Natl Acad Sci U S A. 2008 Apr 8; 105(14):5483-8. Epub 2008 Apr 07.
    View PubMed
  74. Saraf A, Hacker MC, Sitharaman B, Grande-Allen KJ, Barry MA, Mikos AG. Synthesis and conformational evaluation of a novel gene delivery vector for human mesenchymal stem cells. Biomacromolecules. 2008 Mar; 9(3):818-27. Epub 2008 Feb 05.
    View PubMed
  75. Mercier GT, Nehete PN, Passeri MF, Nehete BN, Weaver EA, Templeton NS, Schluns K, Buchl SS, Sastry KJ, Barry MA. Oral immunization of rhesus macaques with adenoviral HIV vaccines using enteric-coated capsules. Vaccine. 2007 Dec 17; 25(52):8687-701.
    View PubMed
  76. Hofherr SE, Mok H, Gushiken FC, Lopez JA, Barry MA. Polyethylene glycol modification of adenovirus reduces platelet activation, endothelial cell activation, and thrombocytopenia. Hum Gene Ther. 2007 Sep; 18: (9)837-48.
    View PubMed
  77. Campos SK, Barry MA. Current advances and future challenges in Adenoviral vector biology and targeting. Current Gene Therapy. 2007 Jun; 7(3):189-204.
    View PubMed
  78. Adams KE, Ke S, Kwon S, Liang F, Fan Z, Lu Y, Hirschi K, Mawad ME, Barry MA, Sevick-Muraca EM. Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer. Journal of Biomedical Optics. 2007 Mar-Apr; 12(2):024017.
    View PubMed
  79. Marsh MP, Campos SK, Baker ML, Chen CY, Chiu W, Barry MA. Cryoelectron microscopy of protein IX-modified adenoviruses suggests a new position for the C terminus of protein IX. J Virol. 2006 Dec; 80: (23)11881-6.
    View PubMed
  80. Chen Z, Mok H, Pflugfelder SC, Li DQ, Barry MA. Improved transduction of human corneal epithelial progenitor cells with cell-targeting adenoviral vectors. Exp Eye Res. 2006 Oct; 83(4):798-806. Epub 2006 Jun 21.
    View PubMed
  81. Kasper FK, Jerkins E, Tanahashi K, Barry MA, Tabata Y, Mikos AG. Characterization of DNA release from composites of oligo(poly(ethylene glycol) fumarate) and cationized gelatin microspheres in vitro. J Biomed Mater Res A. 2006 Sep 15; 78(4):823-35.
    View PubMed
  82. Kasper FK, Young S, Tanahashi K, Barry MA, Tabata Y, Jansen JA, Mikos AG. Evaluation of bone regeneration by DNA release from composites of oligo(poly(ethylene glycol) fumarate) and cationized gelatin microspheres in a critical-sized calvarial defect. J Biomed Mater Res A. 2006 Aug; 78(2):335-42.
    View PubMed
  83. Campos SK, Barry MA. Comparison of adenovirus fiber, protein IX, and hexon capsomeres as scaffolds for vector purification and cell targeting. Virology. 2006 Jun 5; 349(2):453-62. Epub 2006 Feb 28.
    View PubMed
  84. Menezes KM, Mok HS, Barry MA. Increased transduction of skeletal muscle cells by fibroblast growth factor-modified adenoviral vectors. Hum Gene Ther. 2006 Mar; 17(3):314-20.
    View PubMed
  85. Andersson HA, Singh RA, Barry MA. Activation of refractory T cell responses against hepatitis C virus core protein by ablation of interfering hydrophobic domains. Mol Ther. 2006 Feb; 13: (2)338-46.
    View PubMed
  86. Ghosh D, Barry MA. Selection of muscle-binding peptides from context-specific peptide-presenting phage libraries for adenoviral vector targeting. J Virol. 2005 Nov; 79(21):13667-72.
    View PubMed
  87. Kasper FK, Seidlits SK, Tang A, Crowther RS, Carney DH, Barry MA, Mikos AG. In vitro release of plasmid DNA from oligo(poly(ethylene glycol) fumarate) hydrogels. J Controlled Release. 2005 Jun 2; 104(3):521-39.
    View PubMed
  88. Andersson HA, Passeri MF, Barry MA. Rad23 as a reciprocal agent for stimulating or repressing immune responses. Hum Gene Ther. 2005 May; 16(5):634-41.
    View PubMed
  89. Hanks BA, Jiang J, Singh RA, Song W, Barry M, Huls MH, Slawin KM, Spencer DM. Re-engineered CD40 receptor enables potent pharmacological activation of dendritic-cell cancer vaccines in vivo. Nat Med. 2005 Feb; 11(2):130-7.
    View PubMed
  90. Mok H, Palmer DJ, Ng P, Barry MA. Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses. Mol Ther. 2005 Jan; 11(1):66-79.
    View PubMed
  91. Blum JS, Temenoff JS, Park H, Jansen JA, Mikos AG, Barry MA. Development and characterization of enhanced green fluorescent protein and luciferase expressing cell line for non-destructive evaluation of tissue engineering constructs. Biomaterials. 2004 Dec; 25(27):5809-19.
    View PubMed
  92. Campos SK, Barry MA. Rapid construction of capsid-modified adenoviral vectors through bacteriophage lambda Red recombination. Hum Gene Ther. 2004 Nov; 15(11):1125-30.
    View PubMed
  93. McGuire MJ, Sykes KF, Samli KN, Timares L, Barry MA, Stemke-Hale K, Tagliaferri F, Logan M, Jansa K, Takashima A, Brown KC, Johnston SA. A library-selected, Langerhans cell-targeting peptide enhances an immune response. DNA & Cell Biology. 2004 Nov; 23(11):742-52.
    View PubMed
  94. Singh RA, Barry MA. Repertoire and immunofocusing of CD8 T cell responses generated by HIV-1 gag-pol and expression library immunization vaccines. J Immunol. 2004 Oct 1; 173(7):4387-93.
    View PubMed
  95. Andersson HA, Barry MA. Maximizing antigen targeting to the proteasome for gene-based vaccines. Mol Ther. 2004 Sep; 10(3):432-46.
    View PubMed
  96. Barry MA, Howell DP, Andersson HA, Chen JL, Singh RA. Expression library immunization to discover and improve vaccine antigens. Immunol Rev. 2004 Jun; 199:68-83.
    View PubMed
  97. Campos SK, Parrott MB, Barry MA. Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector. Mol Ther. 2004 Jun; 9(6):942-54.
    View PubMed
  98. Mercier GT, Campbell JA, Chappell JD, Stehle T, Dermody TS, Barry MA. A chimeric adenovirus vector encoding reovirus attachment protein sigma1 targets cells expressing junctional adhesion molecule 1. Proc Natl Acad Sci U S A. 2004 Apr 20; 101(16):6188-93.
    View PubMed
  99. Blum JS, Parrott MB, Mikos AG, Barry MA. Early osteoblastic differentiation induced by dexamethasone enhances adenoviral gene delivery to marrow stromal cells. J Orthop Res. 2004 Mar; 22(2):411-6.
    View PubMed
  100. Blum JS, Barry MA, Mikos AG, Jansen JA. In vivo evaluation of gene therapy vectors in ex vivo-derived marrow stromal cells for bone regeneration in a rat critical-size calvarial defect model. Hum Gene Ther. 2003 Dec 10; 14(18):1689-701.
    View PubMed
  101. Howell DP, Krieser RJ, Eastman A, Barry MA. Deoxyribonuclease II is a lysosomal barrier to transfection. Mol Ther. 2003 Dec; 8(6):957-63.
    View PubMed
  102. Blum JS, Barry MA, Mikos AG. Bone regeneration through transplantation of genetically modified cells. Clin Plast Surg. 2003 Oct; 30(4):611-20.
    View PubMed
  103. Parrott MB, Adams KE, Mercier GT, Mok H, Campos SK, Barry MA. Metabolically biotinylated adenovirus for cell targeting, ligand screening, and vector purification. Mol Ther. 2003 Oct; 8(4):688-700.
    View PubMed
  104. Takahashi S, Mok H, Parrott MB, Marini FC 3rd, Andreeff M, Brenner MK, Barry MA. Selection of chronic lymphocytic leukemia binding peptides. Cancer Res. 2003 Sep 1; 63(17):5213-7.
    View PubMed
  105. Barry MA, Campos SK, Ghosh D, Adams KE, Mok H, Mercier GT, Parrott MB. Biotinylated gene therapy vectors. Expert Opinion on Biological Therapy. 2003 Sep; 3(6):925-40.
    View PubMed
  106. Orson FM, Kinsey BM, Bhogal BS, Song L, Densmore CL, Barry MA. Targeted delivery of expression plasmids to the lung via macroaggregated polyethylenimine-albumin conjugates. thods Mol Med. 2003; 75:575-90.
    View PubMed
  107. Singh RA, Rodgers JR, Barry MA. The role of T cell antagonism and original antigenic sin in genetic immunization. J Immunol. 2002 Dec 15; 169(12):6779-86.
    View PubMed
  108. Singh RA, Wu L, Barry MA. Generation of genome-wide CD8 T cell responses in HLA-A*0201 transgenic mice by an HIV-1 ubiquitin expression library immunization vaccine. J Immunol. 2002 Jan 1; 168(1):379-91.
    View PubMed
  109. Parrott MB, Barry MA. Metabolic biotinylation of secreted and cell surface proteins from mammalian cells. Biochem Biophys Res Commun. 2001 Mar 9; 281(4):993-1000.
    View PubMed
  110. Blum JS, Li RH, Mikos AG, Barry MA. An optimized method for the chemiluminescent detection of alkaline phosphatase levels during osteodifferentiation by bone morphogenetic protein 2. J Cell Biochem. 2001; 80(4):532-7.
    View PubMed
  111. Godbey WT, Barry MA, Saggau P, Wu KK, Mikos AG. Poly(ethylenimine)-mediated transfection: a new paradigm for gene delivery. J Biomed Mater Res. 2000 Sep 5; 51(3):321-8.
    View PubMed
  112. Wu L, Barry MA. Fusion protein vectors to increase protein production and evaluate the immunogenicity of genetic vaccines. Mol Ther. 2000 Sep; 2(3):288-97.
    View PubMed
  113. Orson FM, Kinsey BM, Hua PJ, Bhogal BS, Densmore CL, Barry MA. Genetic immunization with lung-targeting macroaggregated polyethyleneimine-albumin conjugates elicits combined systemic and mucosal immune responses. J Immunol. 2000 Jun 15; 164(12):6313-21.
    View PubMed
  114. Levine JA, Abboud L, Barry M, Reed JE, Sheedy PF, Jensen MD. Measuring leg muscle and fat mass in humans: comparison of CT and dual-energy X-ray absorptiometry. J Appl Physiol (1985). 2000 Feb; 88 (2):452-6
    View PubMed
  115. Parrott MB, Barry MA. Metabolic biotinylation of recombinant proteins in mammalian cells and in mice. Mol Ther. 2000 Jan; 1(1):96-104.
    View PubMed
  116. Barry ME, Pinto-Gonzalez D, Orson FM, McKenzie GJ, Petry GR, Barry MA. Role of endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after naked DNA injection. Hum Gene Ther. 1999 Oct 10; 10(15):2461-80.
    View PubMed
  117. Barry MA. Genetic immunization: applying recombinant DNA technology in the immune system to develop new vaccines. Curr Opin Drug Discov Devel. 1999 Mar; 2(2):118-28.
    View PubMed
  118. Tanelian DL, Barry MA, Johnston SA, Le T, Smith GM. Semaphorin III can repulse and inhibit adult sensory afferents in vivo. Nat Med. 1997 Dec; 3(12):1398-401.
    View PubMed
  119. Johnston SA, Barry MA. Genetic to genomic vaccination. Vaccine. 1997 Jun; 15(8):808-9.
    View PubMed
  120. Barry MA, Johnston SA. Biological features of genetic immunization. Vaccine. 1997 Jun; 15(8):788-91.
    View PubMed
  121. Barry MA, Dower WJ, Johnston SA. Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries. Nat Med. 1996 Mar; 2(3):299-305.
    View PubMed
  122. Barry MA, Lai WC, Johnston SA. Protection against mycoplasma infection using expression-library immunization. Nature. 1995 Oct 19; 377(6550):632-5.
    View PubMed
  123. Lai WC, Bennett M, Johnston SA, Barry MA, Pakes SP. Protection against Mycoplasma pulmonis infection by genetic vaccination. DNA & Cell Biology. 1995 Jul; 14(7):643-51.
    View PubMed
  124. Barry MA, Reynolds JE, Eastman A. Etoposide-induced apoptosis in human HL-60 cells is associated with intracellular acidification. Cancer Res. 1993 May 15; 53(10 Suppl):2349-57.
    View PubMed
  125. Barry MA, Eastman A. Identification of deoxyribonuclease II as an endonuclease involved in apoptosis. Arch Biochem Biophys. 1993 Jan; 300(1):440-50.
    View PubMed
  126. Barry MA, Eastman A. Endonuclease activation during apoptosis: the role of cytosolic Ca2+ and pH. Biochem Biophys Res Commun. 1992 Jul 31; 186(2):782-9.
    View PubMed
  127. Eastman A, Barry MA. The origins of DNA breaks: a consequence of DNA damage, DNA repair, or apoptosis? Cancer Invest. 1992; 10(3):229-40.
    View PubMed
  128. Barry MA, Behnke CA, Eastman A. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol. 1990 Nov 15; 40(10):2353-62.
    View PubMed
  129. Sorenson CM, Barry MA, Eastman A. Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. J Natl Cancer Inst. 1990 May 2; 82(9):749-55.
    View PubMed
  130. Eastman A, Barry MA. Interaction of trans-diamminedichloroplatinum(II) with DNA: formation of monofunctional adducts and their reaction with glutathione. Biochemistry. 1987 Jun 16; 26(12):3303-7.
    View PubMed